Company: NCEL
Filing Date: 2025-02-05
Form Type: F-3
Source: 0001213900-25-010223
Chunk: 112

Company: NewcelX Ltd.
Filing Date: 2025-02-05
Form: F-3
Chunk 112
---
 CHF 0.80 to CHF 0.03: 985,723 shares outstanding actual, 645,161 shares outstanding pro forma and 1,630,884 shares outstanding pro forma as adjusted |     |                     |     808,555 |   |     |           |    (754,569 | ) |     |             |      53,986 |   |
| Additional paid-in capital                                                                                                                                                       |     |                     |  62,328,298 |   |     |           |   9,755,862 |   |     |             |  72,084,160 |   |
| Accumulated deficit                                                                                                                                                              |     |                     | (72,409,318 | ) |     |           |           — |   |     |             | (72,409,318 | ) |
| Accumulated other comprehensive loss                                                                                                                                             |     |                     |       4,207 |   |     |           |           — |   |     |             |       4,207 |   |
| Total shareholders’ equity                                                                                                                                                       |     |                     |  (9,268,258 | ) |     |           |   9,001,293 |   |     |             |    (266,965 | ) |
| Total capitalization                                                                                                                                                             |     | $                   |   1,193,458 |   |     | $         |  (1,009,138 | ) |     | $           |     184,320 |   |

The above discussion and table are based on 985,723 Common Shares outstanding as June 30, 2024.

<div align='center'>75

SELLING SHAREHOLDER</div>

The Common Shares being offered by the Selling Shareholder consist of 645,161 of our Common Shares, consisting of: (i) 161,290 Common Shares issued in a private placement pursuant to the December SPA, (ii) 75,000 Common Shares issued pursuant to the October Debt SPA, and (iii) 408,871 Common Shares issuable upon the conversion of certain of the Company’s PPC pursuant to the October Debt SPA.

On December 4, 2024, we entered into the December SPA, with Selling Shareholder. Pursuant to the terms of the December SPA, we agreed to issue and sell to the investor, in a private placement offering, up to 322,580 Common Shares at a purchase price of $3.10 per Common Share for aggregate gross proceeds of